University Hospital Basel
Basel, Canton of Basel-City, 4031, Switzerland
Location status: Recruiting
NCT Number: NCT07643610
This regulation defines the purpose, the operational processes, and the organization of the registry BEAT-SHOCK (Basel Evaluation of Acute Therapy in cardiogenic SHOCK). It describes the requirements for collecting, storing, processing, managing and sharing health-related registry data.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Basel, Canton of Basel-City, 4031, Switzerland
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Exclusion criteria
This is a health data registry.
Time frame: 10 years
In-hospital all-cause mortality is defined as death occurring before discharge from the participating study centre. Deaths occurring after transfer to an external hospital are not counted as in-hospital deaths, but are captured through follow-up for 30-day and 90-day mortality.
Time frame: 30, 90 days
30-day and 90-day all-cause mortality occuring after discharge from the participating study centre.
Time frame: 30, 60, 360 days
The need for organ support at any time during hospitalization (including renal replacement therapy, mechanical circulation support irrespective of type, and vasoactive or inotropic therapy)
Time frame: Within 36 hours after index diagnosis of cardiogenic shock/ index presentation.
Occurence of AKI (defined as an increase in serum creatinine of at least 26 µmol/L (0.3 mg/dL)
Interested in participating?
Request InfoUniversity Hospital, Basel, Switzerland
Other
BEAT-SHOCK (Basel Evaluation of Acute Therapy in Cardiogenic SHOCK) Registry
Acronym: BEAT-SHOCK
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07817472
Cardiogenic Shock, Cardiovascular Diseases
Gwangju, South Korea
View Trial DetailsNCT07825363
Acute Decompensated Heart Failure, Acute Myocardial Infarction
Weston, Florida, United States
View Trial DetailsNCT06955936
Cardiogenic Shock, Cardiovascular Diseases
Tomsk, Russia
View Trial DetailsNCT07597291
Cardiogenic Shock, Cardiogenic Shock Acute
Carnaxide, Lisbon District, Portugal
View Trial Details